<SEC-DOCUMENT>0001193125-22-258944.txt : 20221006
<SEC-HEADER>0001193125-22-258944.hdr.sgml : 20221006
<ACCEPTANCE-DATETIME>20221006171704
ACCESSION NUMBER:		0001193125-22-258944
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221006
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221006
DATE AS OF CHANGE:		20221006

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHPEAK PROPERTIES, INC.
		CENTRAL INDEX KEY:			0000765880
		STANDARD INDUSTRIAL CLASSIFICATION:	REAL ESTATE INVESTMENT TRUSTS [6798]
		IRS NUMBER:				330091377
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08895
		FILM NUMBER:		221298743

	BUSINESS ADDRESS:	
		STREET 1:		5050 SOUTH SYRACUSE STREET
		STREET 2:		SUITE 800
		CITY:			DENVER
		STATE:			CO
		ZIP:			80237
		BUSINESS PHONE:		949-407-0700

	MAIL ADDRESS:	
		STREET 1:		5050 SOUTH SYRACUSE STREET
		STREET 2:		SUITE 800
		CITY:			DENVER
		STATE:			CO
		ZIP:			80237

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCP, INC.
		DATE OF NAME CHANGE:	20070911

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTH CARE PROPERTY INVESTORS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d335330d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:peak="http://www.healthpeak.com/20221006" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-10-06_to_2022-10-06">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-10-06_to_2022-10-06">0000765880</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="peak-20221006.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-10-06_to_2022-10-06"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-10-06</xbrli:startDate> <xbrli:endDate>2022-10-06</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-10-06_to_2022-10-06">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-10-06_to_2022-10-06" format="ixt:datemonthdayyearen">October&#160;6, 2022</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2022-10-06_to_2022-10-06">Healthpeak Properties, Inc.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-10-06_to_2022-10-06" format="ixt-sec:stateprovnameen">Maryland</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-10-06_to_2022-10-06">001-08895</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-10-06_to_2022-10-06">33-0091377</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-10-06_to_2022-10-06">5050 South Syracuse Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2022-10-06_to_2022-10-06">Suite 800</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-10-06_to_2022-10-06">Denver</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-10-06_to_2022-10-06">CO</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-10-06_to_2022-10-06">80237</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, include area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-10-06_to_2022-10-06">(720)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-10-06_to_2022-10-06">428-5050</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-10-06_to_2022-10-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-10-06_to_2022-10-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-10-06_to_2022-10-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-10-06_to_2022-10-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-10-06_to_2022-10-06">Common stock, $1.00 par value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-10-06_to_2022-10-06">PEAK</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-10-06_to_2022-10-06" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-10-06_to_2022-10-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Thomas M. Herzog Stepping Down as Chief Executive Officer and Director </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;6, 2022, Healthpeak Properties, Inc. (the &#8220;Company&#8221;) and Thomas M. Herzog mutually agreed that Mr.&#160;Herzog would step down from his position as Chief Executive Officer and from the board of directors (the &#8220;Board&#8221;) of the Company, effective immediately. Mr.&#160;Herzog&#8217;s decision to step down was not due to any disagreements on any matter relating to the Company&#8217;s operations, policies or practices. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr.&#160;Herzog stepping down from his position, subject to his execution and <span style="white-space:nowrap">non-revocation</span> of an effective release agreement (the &#8220;Release Agreement&#8221;) and compliance with certain restrictive covenants set forth in the Release Agreement, Mr.&#160;Herzog will be entitled to receive the following severance payments and benefits under the Company&#8217;s Executive Severance Plan (as amended, the &#8220;Severance Plan&#8221;): </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">An amount in cash equal to three times the sum of (i)&#160;Mr.&#160;Herzog&#8217;s base salary plus (ii)&#160;the greater of his target annual bonus or his actual 2021 annual bonus; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">A <span style="white-space:nowrap">pro-rated</span> 2022 annual bonus, based on actual performance (except that the portion of the bonus based on individual performance (<span style="font-style:italic">i.e. </span>forty percent (40%) of such bonus) will be no less than Mr.&#160;Herzog&#8217;s target bonus attributable to such portion); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Continued vesting of Mr.&#160;Herzog&#8217;s outstanding time-based restricted stock units covering Company common stock in accordance with their terms for twenty-four months following separation, after which any remaining unvested portion of such restricted stock units will fully vest; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Continued vesting of Mr.&#160;Herzog&#8217;s outstanding performance-based restricted stock units covering Company common stock in accordance with their terms with respect to the applicable performance requirements (with such awards becoming fully vested with respect to any time-based vesting requirements); and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">An amount equal to three years of Mr.&#160;Herzog&#8217;s monthly COBRA premiums. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company expects to record an accounting charge for severance and related expenses of approximately $25 million to $30 million upon execution of the Release Agreement. This does not represent the actual value of Mr. Herzog&#8217;s severance payments and benefits, which will depend on a number of factors, including but not limited to the Company&#8217;s future stock price and future total shareholder return, and, accordingly, cannot be quantified with any certainty at this time. The foregoing description of the Release Agreement does not purport to be complete and is qualified in its entirety by the full text of the Release Agreement, a copy of which is filed herewith as Exhibit 10.1 and incorporated by reference herein. Further, the foregoing description of the Severance Plan does not purport to be complete and is qualified in its entirety by the full text of the Severance Plan, a copy of which was filed as Exhibit 10.3 to the Company&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the quarterly period ended September&#160;30, 2016, filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on November&#160;1, 2016, and which was amended as described in the Company&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the quarterly period ended June&#160;30, 2022, as filed with the SEC on August&#160;3, 2022, and is incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Appointment of Scott M. Brinker as President and Chief Executive Officer and Election as Director</span> </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;6, 2022, the Board appointed Scott M. Brinker, the Company&#8217;s President and Chief Investment Officer, as President and Chief Executive Officer, and elected him to the Board, effective immediately. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Brinker, age 46, served as President and Chief Investment Officer of the Company since January 2020. He was previously Executive Vice President and Chief Investment Officer of the Company. Prior to joining the Company in 2018, Mr.&#160;Brinker served in various investment and portfolio management-related roles at Welltower Inc., a healthcare REIT, between July 2001 and January 2017, most recently as its Executive Vice President and Chief Investment Officer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following his appointment, Mr.&#160;Brinker will be eligible to receive the severance benefits provided to the Chief Executive Officer of the Company under the Severance Plan and the Company&#8217;s Executive Change in Control Severance Plan (the &#8220;CIC Severance Plan&#8221;). </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the CIC Severance Plan does not purport to be complete and is qualified in its entirety by the full text of the CIC Severance Plan, a copy of which was filed as Exhibit 10.4 to the Company&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the quarterly period ended September&#160;30, 2016, filed with the SEC on November&#160;1, 2016, and which was amended as described in the Company&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the quarterly period ended June&#160;30, 2022, as filed with the SEC on August&#160;3, 2022, and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;7.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the Company&#8217;s press release announcing changes to the executive team, including the departure of Mr.&#160;Herzog as Chief Executive Officer and a member of the Board, and the appointment of Mr.&#160;Brinker as Chief Executive Officer and a member of the Board is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K,</span> and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in Item 7.01 to this Current Report on Form <span style="white-space:nowrap">8-K,</span> including Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d335330dex101.htm">Release Agreement for Thomas M. Herzog, dated October 6, 2022 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d335330dex991.htm">Press Release, dated October&#160;6, 2022 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Healthpeak Properties, Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: October&#160;6, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Peter A. Scott</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Peter A. Scott</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d335330dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RELEASE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
Release Agreement (this &#147;<B>Release Agreement</B>&#148;) is entered into this 6th day of October&nbsp;2022, by and between Thomas M. Herzog, an individual (&#147;<B>Executive</B>&#148;), and Healthpeak Properties, Inc., a Maryland corporation
(the &#147;<B>Company</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Executive has been employed by the Company; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Executive&#146;s employment by the Company has terminated effective as of October&nbsp;6, 2022 (the &#147;<B>Separation
Date</B>&#148;) and, as a condition to Executive&#146;s receipt of certain severance benefits under the Company&#146;s Executive Severance Plan (as amended, the &#147;<B>Plan</B>&#148;), the Company and Executive desire to enter into this Release
Agreement upon the terms set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the covenants undertaken and the release contained
in this Release Agreement, and in consideration of the obligations of the Company (or one of its subsidiaries) to pay severance benefits (subject to and conditioned upon Executive&#146;s timely execution and
<FONT STYLE="white-space:nowrap">non-revocation</FONT> of this Release Agreement and compliance with the other terms and conditions contained herein) under and pursuant to the Plan, Executive and the Company agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B> <B><U>Separation Date</U></B>. Effective as of the Separation Date, Executive&#146;s status as the Company&#146;s Chief Executive
Officer, as a member of the Company&#146;s board of directors and as an employee, officer and director of the Company and its affiliates terminated. Executive shall, at the Company&#146;s request, execute and deliver to the Company Executive&#146;s
resignation from all such directorships. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.</B> <B><U>Release</U></B>. Executive, on behalf of himself, his descendants, dependents,
heirs, executors, administrators, assigns, and successors, and each of them, hereby acknowledges full and complete satisfaction of and covenants not to sue and fully releases and discharges the Company and each of its parents, subsidiaries and
affiliates, past and present, as well as its and their trustees, directors, officers, members, managers, partners, agents, attorneys, insurers, employees, stockholders, representatives, assigns, and successors, past and present, and each of them,
hereinafter together and collectively referred to as the &#147;<B>Releasees</B>,&#148; with respect to and from any and all claims, wages, demands, rights, liens, agreements or contracts (written or oral), covenants, actions, suits, causes of
action, obligations, debts, costs, expenses, attorneys&#146; fees, damages, judgments, orders and liabilities of whatever kind or nature in law, equity or otherwise, whether now known or unknown, suspected or unsuspected, and whether or not
concealed or hidden (each, a &#147;<B>Claim</B>&#148;), which he now owns or holds or he has at any time heretofore owned or held or may in the future hold as against any of said Releasees (including, without limitation, any Claim arising out of or
in any way connected with Executive&#146;s service as an officer, director, employee, member, stockholder or manager of any Releasee, Executive&#146;s separation from his position as an officer, director, employee, manager, stockholder and/or
member, as applicable, of any Releasee, or any other transactions, occurrences, acts or omissions or any loss, damage or injury whatever), whether known or unknown, suspected or unsuspected, resulting from any act or omission by or on the part of
said Releasees, or any of them, committed or omitted prior to the date on which Executive signs this Release Agreement, including, without limiting the generality </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the foregoing, any Claim under Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act, the Family and Medical Leave
Act of 1993, the California Fair Employment and Housing Act; the California Family Rights Act, the California Labor Code, California Wage Orders, California Business&nbsp;&amp; Professions Code Section&nbsp;17200, the Colorado Anti-Discrimination
Act (CADA), the Colorado Lawful <FONT STYLE="white-space:nowrap">Off-Duty</FONT> Activities Statute (LODA), the Colorado Personnel Files Employee Inspection Right Statute, the Colorado Labor Peace Act, the Colorado Labor Relations Act, the Colorado
Equal Pay Act, the Colorado Minimum Wage Order, the Colorado Genetic Information <FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> Act, or any other federal, state or local law, regulation, or ordinance, or any Claim for severance pay, bonus,
sick leave, holiday pay, vacation pay, life insurance, health or medical insurance or any other fringe benefit, workers&#146; compensation or disability; provided however, that the foregoing release shall not apply to: (a)&nbsp;Executive&#146;s
right to receive the Severance Benefits (as defined below), which Severance Benefits (among other things) are good and valuable consideration for this Release Agreement (subject to Section&nbsp;4 hereof); (b) any rights Executive has in
Executive&#146;s capacity as a holder of any equity-based awards previously granted by the Company to Executive, to the extent that such awards continue after the termination of Executive&#146;s employment with the Company in accordance with the
terms and conditions of the Plan (subject to Section&nbsp;4 hereof); (c) any right to indemnification that Executive may have pursuant to the Sixth Amended and Restated Bylaws of the Company, its corporate charter or under any written
indemnification agreement with the Company (or any corresponding provision of any subsidiary or affiliate of the Company) with respect to any loss, damages or expenses (including but not limited to attorneys&#146; fees to the extent otherwise
provided) that Executive may in the future incur with respect to his service as an employee, officer or director of the Company or any of its subsidiaries or affiliates; (d)&nbsp;any rights that Executive may have to insurance coverage for losses,
damages or expenses described under the foregoing clause (c)&nbsp;under any Company (or subsidiary or affiliate) directors and officers liability insurance policy; (e)&nbsp;any rights to continued medical or dental coverage that Executive may have
under COBRA; (f)&nbsp;any rights to payment of benefits that Executive may have under a retirement plan sponsored or maintained by the Company that is intended to qualify under Section&nbsp;401(a) of the Internal Revenue Code of 1986, as amended; or
(g)&nbsp;any vested deferred compensation or supplemental retirement benefits that Executive may be entitled to under a nonqualified deferred compensation or supplemental retirement plan of the Company. In addition, this release does not cover any
Claim that cannot be so released as a matter of applicable law. Executive acknowledges and agrees that he has received any and all leave and other benefits that he has been and is entitled to pursuant to the Family and Medical Leave Act of 1993.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B> <B><U>Acknowledgment of Payment of Wages; Severance</U></B>. Except for accrued vacation (which the parties agree totals
approximately 228 hours of pay) and salary for the pay period in which the Separation Date occurred, Executive acknowledges that he has received all amounts owed for his or her regular and usual salary (including, but not limited to, any bonus or
other wages) and usual benefits through the date of this Release Agreement. Provided Executive timely executes this Release Agreement and does not revoke the release of Claims set forth in this Release Agreement, such that this Release Agreement
becomes effective and irrevocable on the eighth (8<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day after Executive executes this Release Agreement, and subject to Section&nbsp;4 hereof, the Company shall pay or provide (as applicable) to
Executive the payments and benefits provided for under Section&nbsp;5 of the Plan (the &#147;<B>Severance Benefits</B>&#148;), subject to the terms and conditions of the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B> <B><U>Clawback</U></B>. In the event that (a)&nbsp;Executive breaches any of
Executive&#146;s obligations, agreements or covenants under this Release Agreement or otherwise imposed by law, or (b)&nbsp;the Company determines, following the Separation Date, that circumstances existed on or prior to the Separation Date that
would have constituted &#147;Cause&#148; (as defined in the Plan) under clauses (iv), (v) or (vi)&nbsp;thereof for the Company to terminate Executive&#146;s employment (subject to Section&nbsp;16 below in the event of any dispute between the Company
and Executive as to whether &#147;Cause&#148; existed), the Company will be entitled to (i)&nbsp;cease paying any then-unpaid Severance Benefits, and (ii)&nbsp;recover any previously-paid Severance Benefits from Executive, including, without
limitation, the proceeds received from the sale of any shares of Company common stock acquired by Executive in connection with the acceleration or continued vesting of Executive&#146;s equity awards under the Plan in connection with his termination
of employment with the Company, and the Company will be entitled to obtain all other relief provided by law or equity. Executive agrees to promptly repay to the Company, within ten (10)&nbsp;days after written demand therefor, any Severance Benefits
that the Company is entitled to recover pursuant to the preceding sentence. Further, any Severance Benefits which are subject to recovery under any law, government regulation, order or stock exchange listing requirement, or under any policy of the
Company adopted from time to time, will be subject to such deductions and clawback (recovery) as may be required to be made pursuant to such law, government regulation, order, stock exchange listing requirement or policy of the Company. Executive
specifically authorizes the Company to withhold from future wages or future payments of Severance Benefits any amounts that may become due under this Section&nbsp;4. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B> <B><U>Waiver of Unknown and Unsuspected Claims</U></B>. It is the intention of Executive in executing this Release Agreement that the
same shall be effective as a bar to each and every Claim hereinabove specified. In furtherance of this intention, Executive hereby expressly waives any and all rights and benefits conferred upon him or her by the provisions of Section&nbsp;1542 of
the California Civil Code (&#147;<B>Section</B><B></B><B>&nbsp;1542</B>&#148;), as well as any other similar statute or common law doctrine that may apply, and expressly consents that this Release Agreement shall be given full force and effect
according to each and all of its express terms and provisions, including those related to unknown and unsuspected Claims, if any, as well as those relating to any other Claims hereinabove specified. Section&nbsp;1542 provides: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT
THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive acknowledges that he may hereafter discover Claims or facts in addition to or different from those which Executive now knows or believes to exist
with respect to the subject matter of this Release Agreement and which, if known or suspected at the time of executing this Release Agreement, may have materially affected this settlement. Nevertheless, Executive hereby waives any right, Claim or
cause of action that might arise as a result of such different or additional Claims or facts. Executive acknowledges that he understands the significance and consequences of such release and such specific waiver of Section&nbsp;1542 and any similar
applicable statute or doctrine of law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.</B> <B><U>ADEA Waiver</U></B>. Executive expressly acknowledges and agrees that by
entering into this Release Agreement, Executive is waiving any and all rights or Claims that he may have arising under the Age Discrimination in Employment Act of 1967, as amended (the &#147;<B>ADEA</B>&#148;), which have arisen on or before the
date of execution of this Release Agreement. Executive further expressly acknowledges and agrees that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> In return for this
Release Agreement, Executive will receive consideration beyond that which Executive was already entitled to receive before entering into this Release Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Executive is hereby advised in writing by this Release Agreement that Executive has the right to and should consult with an attorney
before signing this Release Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Executive has voluntarily chosen to enter into this Release Agreement and has not been
forced or pressured in any way to sign it; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> Executive was given a copy of this Release Agreement on October&nbsp;6, 2022 and
informed that he had 21 days within which to consider this Release Agreement and that if he wished to execute this Release Agreement prior to expiration of such <FONT STYLE="white-space:nowrap">21-day</FONT> period, he should execute the Endorsement
attached hereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Executive was informed that he had seven days following the date of his execution of this Release Agreement in
which to revoke this Release Agreement, and this Release Agreement will become null and void if Executive revokes this Release Agreement during that time. Any revocation must be in writing and must be received by the Company during the <FONT
STYLE="white-space:nowrap">seven-day</FONT> revocation period. In the event that Executive exercises his right of revocation, neither the Company nor Executive will have any obligations under this Release Agreement and Executive will not become
entitled to the Severance Benefits; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Executive understands that this Release Agreement shall become effective, irrevocable, and
binding upon Executive on the eighth (8<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day after his execution of it, so long as Executive has not revoked it within the time period and in the manner specified in clause (e)&nbsp;above; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> Nothing in this Release Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the
validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs from doing so, unless specifically authorized by federal law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.</B> <B><U>No Transferred Claims; No Admission of Liability</U></B>. Executive warrants and represents that Executive has not heretofore
assigned or transferred to any person not a party to this Release Agreement any released matter or any part or portion thereof and he shall defend, indemnify and hold the Releasees harmless from and against any claim (including the payment of
attorneys&#146; fees and costs actually incurred whether or not litigation is commenced) based on or in connection with or arising out of any such assignment or transfer made, purported or claimed. It is the intention of the parties that this
indemnity does not require payment as a condition precedent to recovery by the Releasees against Executive under this indemnity. Executive understands that neither the payment of any sum of money nor the execution of this Release Agreement shall
constitute or be construed as an admission of any liability whatsoever by the Releasees, or any of them, who have consistently taken the position that they have no liability whatsoever to Executive. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.</B> <B><U>Covenants</U></B>. Executive by executing this Release Agreement expressly
agrees to each of the following provisions of this Section&nbsp;8: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Confidentiality</B>. Executive shall not at any time
directly or indirectly, disclose or make available to any person, firm, corporation, association or other entity for any reason or purpose whatsoever, any Confidential Information (as defined below); provided, however, that this Section&nbsp;8(a)
shall not apply when (i)&nbsp;disclosure is required by law or by any court, arbitrator, mediator or administrative or legislative body (including any committee thereof) with apparent jurisdiction to order Executive to disclose or make available
such information (provided, however, that Executive shall promptly notify the Company in writing upon receiving a request for such information), or (ii)&nbsp;with respect to any other litigation, arbitration or mediation involving this Release
Agreement, including but not limited to enforcement of this Release Agreement. As of the date of this Release Agreement, all Confidential Information in Executive&#146;s possession that is in written, digital or other tangible form (together with
all copies or duplicates thereof, including computer files) has been returned to the Company and has not been retained by Executive or furnished to any third party, in any form except as provided herein; provided, however, that Executive shall not
be obligated to treat as confidential, or return to the Company copies of any Confidential Information that (x)&nbsp;was publicly known at the time it was disclosed to Executive, (y)&nbsp;becomes publicly known or available thereafter other than by
any means in violation of the Plan or any other duty owed to the Company by any person or entity, or (z)&nbsp;is lawfully disclosed to Executive by a third party. As used in this Release Agreement, the term &#147;<B>Confidential
Information&#148;</B> means: information disclosed to Executive or known by Executive as a consequence of or through Executive&#146;s relationship with the Company, about the suppliers, customers, employees, business methods, public relations
methods, organization, procedures or finances, including, without limitation, information of or relating to supplier lists or customer lists, of the Company and its affiliates (collectively, the &#147;<B>Company Group</B>&#148;). Notwithstanding
anything set forth in this Release Agreement to the contrary, Executive shall not be prohibited from reporting possible violations of federal or state law or regulation to any governmental agency or entity or making other disclosures that are
protected under the whistleblower provisions of federal or state law or regulation, nor is Executive required to notify the Company regarding any such reporting, disclosure or cooperation with the government. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Noncompetition</B>. Executive acknowledges that the nature of the Company Group&#146;s business and Executive&#146;s position
with the Company is such that if Executive were to become employed by, or substantially involved in, the business of a competitor of the Company Group during the 12 months following the termination of Executive&#146;s employment with the Company, it
would not be possible, or would be very difficult, for Executive not to rely on or use the Company Group&#146;s trade secrets and Confidential Information. Thus, to avoid the inevitable disclosure of the Company Group&#146;s trade secrets and
Confidential Information, and to protect such trade secrets and Confidential Information and the Company Group&#146;s relationships and goodwill with customers, for a period of 12 months after the termination date (the &#147;<B>Restricted
Period</B>&#148;), Executive will not directly or indirectly engage in (whether as an employee, consultant, agent, proprietor, principal, partner, stockholder, corporate officer, director or otherwise), nor have any ownership interest in, or
participate in the financing, operation, management or control of, any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
person, firm, corporation or business anywhere in the United States and Mexico (the &#147;<B>Restricted Area</B>&#148;) that competes with any member of the Company Group in the healthcare real
estate acquisition, development, leasing, management, investment or financing industry (a &#147;<B>Competing Business</B>&#148;); provided, that Executive may purchase and hold only for investment purposes less than two percent of the shares of any
corporation in competition with the Company Group whose shares are regularly traded on a national securities exchange. Notwithstanding the preceding sentence, in the event Executive accepts employment with or provides services to a business (the
&#147;<B>Service Recipient</B>&#148;) that is affiliated with another business that engages in a Competing Business or which derives a de minimis portion of its gross revenues from Competing Businesses, Executive&#146;s employment by or service to
the Service Recipient shall not constitute a breach by Executive of his or her obligations pursuant to this Section&nbsp;6(b) so long as each of the following conditions is satisfied at all times during the Restricted Period and while Executive is
employed by or providing service to the Service Recipient: (i)&nbsp;no more than 10% of the gross revenues of the Service Recipient are derived from Competing Businesses; (ii)&nbsp;no more than 10% of the gross revenues of the Service Recipient and
those entities that (directly or through one or more intermediaries) are controlled by, control, or are under common control with such Service Recipient, together on a consolidated basis, are derived from Competing Businesses; and (iii)&nbsp;in the
course of Executive&#146;s services for the Service Recipient, a material portion (no more than 10%) of Executive&#146;s services are not directly involved in or responsible for any Competing Business. The foregoing covenants in this
Section&nbsp;8(b) shall continue in effect through the entire Restricted Period regardless of whether Executive is then entitled to receive any Severance Benefits from the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> of Employees</B>. During the Restricted Period, Executive shall not
directly or indirectly solicit, induce, attempt to hire, recruit, encourage, take away, or hire any employee or independent contractor of the Company Group whose annual rate of compensation is then $50,000 or more or cause any such Company Group
employee or contractor to leave his or her employment or engagement with the Company Group either for employment with Executive or for any other entity or person. The foregoing covenants in this Section&nbsp;8(c) shall continue in effect through the
entire Restricted Period regardless of whether Executive is then entitled to receive any Severance Benefits from the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B>
<B><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> of Customers</B>. During the Restricted Period, Executive shall not directly or indirectly influence or attempt to influence customers, vendors, suppliers, licensors, lessors, joint
venturers, associates, consultants, agents, or partners of the Company Group to divert their business away from the Company Group to any Competing Business, and Executive agrees not to otherwise interfere with, disrupt or attempt to disrupt the
business relationships, contractual or otherwise, between any member of the Company Group and any of its customers, suppliers, vendors, lessors, licensors, joint venturers, associates, officers, employees, consultants, managers, partners, members or
investors. The foregoing covenants in this Section&nbsp;8(d) shall continue in effect through the entire Restricted Period regardless of whether Executive is then entitled to receive any Severance Payments from the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B><FONT STYLE="white-space:nowrap">Non-Disparagement</FONT></B>. During Executive&#146;s employment with the Company Group and
thereafter, Executive shall not make any statement, publicly or privately, that would or would be reasonably expected to disparage the Company or its affiliates or subsidiaries, or any of their respective officers, directors, employees, or agents.
Nothing in this Agreement or otherwise prevents Executive from making any truthful statement (a)&nbsp;to the extent required or protected by law or legal process or (b)&nbsp;to a governmental agency or any judicial, arbitral or self-regulatory
forum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Disclosures</B>.&nbsp;The Company agrees that, with respect to any statements
or communications relating to Executive&#146;s service as (or departure as) an employee and/or Chief Executive Officer of the Company and/or a member of the Company&#146;s Board of Directors that are intended for mass distribution to the
Company&#146;s employees and/or the public, the Company will provide Executive with a reasonable opportunity to review and comment on such statements and communications prior to their distribution; provided, that this Section&nbsp;8(f) shall not
prohibit the Company from making statements or communications (including filings with the Securities and Exchange Commission) that legal counsel advises the Company are required or protected by applicable law or legal process. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> <B>Understanding of Covenants</B>. Executive, by signing this Release Agreement, represents as follows: Executive (i)&nbsp;is
familiar with the foregoing covenants set forth in this Section&nbsp;8, (ii) is fully aware of Executive&#146;s obligations hereunder, (iii)&nbsp;agrees to the reasonableness of the length of time, scope and geographic coverage of the foregoing
covenants set forth in this Section&nbsp;8, (iv) agrees that the Company Group currently conducts business throughout the Restricted Area and (v)&nbsp;agrees that such covenants are necessary to protect the Company Group&#146;s confidential and
proprietary information, goodwill, stable workforce, and customer relations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> <B>Right to Injunctive and Equitable Relief</B>.
Executive&#146;s obligations not to disclose or use Confidential Information and to refrain from the solicitations described in this Section&nbsp;8 are of a special and unique character, which gives them a peculiar value. The Company cannot be
reasonably or adequately compensated in damages in an action at law in the event Executive breaches such obligations, and the breach of such obligations would cause irreparable harm to the Company. Therefore, the Company shall be entitled to
injunctive and other equitable relief without bond or other security in the event of such breach in addition to any other rights or remedies which the Company may possess. Furthermore, Executive&#146;s obligations and the rights and remedies of the
Company under this Section&nbsp;8 are cumulative and in addition to, and not in lieu of, any obligations, rights, or remedies created by applicable law relating to misappropriation or theft of trade secrets or confidential information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> <B>Cooperation</B>. Executive shall respond to all reasonable inquiries of the Company about any matters concerning the Company or
its affairs that occurred or arose during Executive&#146;s employment by the Company, and Executive shall reasonably cooperate with the Company in investigating, prosecuting and defending any charges, claims, demands, liabilities, causes of action,
lawsuits or other proceedings by, against or involving the Company relating to the period during which Executive was employed by the Company or relating to matters of which Executive had or should have had knowledge or information. Further, except
as required by law, Executive will at no time voluntarily serve as a witness or offer written or oral testimony against the Company in conjunction with any complaints, charges or lawsuits brought against the Company by or on behalf of any current or
former employees, or any governmental or administrative agencies related to Executive&#146;s period of employment and will provide the Company with notice of any subpoena or other request for such information or testimony. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.</B> <B><U>Certain Exceptions;</U></B> <B><U>Defend Trade Secrets Act Notice of
Immunity Rights</U></B>. Nothing herein shall be construed to prohibit Executive from communicating directly with, cooperating with, or providing information to, any government regulator, including, but not limited to, the U.S.&nbsp;Securities and
Exchange Commission, the U.S.&nbsp;Commodity Futures Trading Commission, or the U.S.&nbsp;Department of Justice. Executive acknowledges that the Company has provided Executive with the following notice of immunity rights in compliance with the
requirements of the Defend Trade Secrets Act: (i)&nbsp;Executive shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of proprietary information that is made in confidence to a Federal, State,
or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, (ii)&nbsp;Executive shall not be held criminally or civilly liable under any Federal or State trade secret law for the
disclosure of proprietary information that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal, and (iii)&nbsp;if Executive files a lawsuit for retaliation by the Company for reporting a
suspected violation of law, Employee may disclose the proprietary information to his or her attorney and use the proprietary information in the court proceeding, if Executive files any document containing the proprietary information under seal, and
does not disclose the proprietary information, except pursuant to court order. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.</B> <B><U>Severability</U></B>. It is the desire
and intent of the parties hereto that the provisions of this Release Agreement be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any
particular provision of this Release Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable under any present or future law, such provision, as to such jurisdiction, shall be ineffective,
without invalidating the remaining provisions of this Release Agreement or affecting the validity or enforceability of such provision in any other jurisdiction; furthermore, in lieu of such invalid or unenforceable provision there will be added
automatically as a part of this Release Agreement, a legal, valid and enforceable provision as similar in terms to such invalid or unenforceable provision as may be possible. Notwithstanding the foregoing, if such provision could be more narrowly
drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Release Agreement or affecting the validity or
enforceability of such provision in any other jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.</B> <B><U>Counterparts</U></B>. This Release Agreement may be executed
in separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.</B> <B><U>Governing Law</U></B>. THIS RELEASE AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH UNITED STATES FEDERAL LAW
AND, TO THE EXTENT NOT PREEMPTED BY UNITED STATES FEDERAL LAW, THE LAWS OF THE STATE OF COLORADO, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICTING PROVISION OR RULE (WHETHER OF THE STATE OF COLORADO OR ANY OTHER JURISDICTION) THAT WOULD
CAUSE THE LAWS OF ANY JURISDICTION OTHER THAN UNITED STATES FEDERAL LAW AND THE LAW OF THE STATE OF COLORADO TO BE APPLIED. IN FURTHERANCE OF THE FOREGOING, APPLICABLE FEDERAL LAW AND, TO THE EXTENT NOT PREEMPTED BY APPLICABLE FEDERAL LAW, THE
INTERNAL LAW OF THE STATE OF COLORADO, WILL CONTROL THE INTERPRETATION AND CONSTRUCTION OF THIS RELEASE AGREEMENT, EVEN IF UNDER SUCH JURISDICTION&#146;S CHOICE OF LAW OR CONFLICT OF LAW ANALYSIS, THE SUBSTANTIVE LAW OF SOME OTHER JURISDICTION WOULD
ORDINARILY APPLY. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.</B> <B><U>Amendment and Waiver</U></B>. The provisions of this Release Agreement may
be amended and waived only with the prior written consent of the Company and Executive, and no course of conduct or failure or delay in enforcing the provisions of this Release Agreement shall be construed as a waiver of such provisions or affect
the validity, binding effect or enforceability of this Release Agreement or any provision hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.</B> <B><U>Descriptive
Headings</U></B>. The descriptive headings of this Release Agreement are inserted for convenience only and do not constitute a part of this Release Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.</B> <B><U>Construction</U></B>. Where specific language is used to clarify by example a general statement contained herein, such
specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates. The language used in this Release Agreement shall be deemed to be the language chosen by the parties to
express their mutual intent, and no rule of strict construction shall be applied against any party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>16.</B> <B><U>Arbitration</U></B>.
Any claim or controversy arising out of or relating to this Release Agreement shall be submitted to arbitration in accordance with the arbitration provision set forth in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.</B> <B><U>Nouns and Pronouns</U></B>. Whenever the context may require, any pronouns used herein shall include the corresponding
masculine, feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural and vice-versa. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.</B>
<B><U>Legal Counsel</U></B>. Each party recognizes that this is a legally binding contract. Executive acknowledges and agrees that he has read and understands this Release Agreement completely, is entering into it freely and voluntarily, and has
been advised to seek legal counsel of his own choice prior to entering into this Release Agreement and he has had ample opportunity to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*** </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[The remainder of this
page is left blank intentionally.] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned have read and understood the consequences of this Release Agreement and have
voluntarily signed it. The undersigned declare under penalty of perjury under the laws of the State of Colorado that the foregoing is true and correct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">EXECUTED this 6th day of October&nbsp;2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EXECUTIVE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas M. Herzog</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thomas M. Herzog</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HEALTHPEAK PROPERTIES, INC.</B>,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a Maryland
corporation</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">By: /s/ Peter A. Scott</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name: Peter A. Scott</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: Chief Financial Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ENDORSEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I, Thomas M. Herzog, hereby acknowledge that I was given 21 days to consider the foregoing Release Agreement and voluntarily chose to sign the
Release Agreement prior to the expiration of the <FONT STYLE="white-space:nowrap">21-day</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I declare under penalty of
perjury under the laws of the United States and the State of Colorado that the foregoing is true and correct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">EXECUTED this 6th day of
October&nbsp;2022, at <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas M. Herzog</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Thomas M. Herzog</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d335330dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Healthpeak Properties Announces Changes to Executive Team </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Scott Brinker Appointed President and Chief Executive Officer and Elected as Member of the Board </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Tom Herzog Steps Down as Chief Executive Officer and Board Director </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Scott Bohn Named Chief Development Officer and Adam Mabry Appointed Chief Investment Officer </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DENVER, Oct.&nbsp;6, 2022 /PRNewswire/ &#150; Healthpeak Properties, Inc. (NYSE: PEAK) today announced that its Board of Directors (the &#147;Board&#148;) has
appointed Scott Brinker, the Company&#146;s President and Chief Investment Officer, as President and Chief Executive Officer, and elected him to the Healthpeak Board, effective immediately. Mr.&nbsp;Brinker succeeds Tom Herzog, who mutually agreed
with the Board to step down as Chief Executive Officer and from the Board to pursue other endeavors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthpeak also announced that Scott Bohn, Executive
Vice President &#150; <FONT STYLE="white-space:nowrap">Co-Head</FONT> of Life Science, was appointed Chief Development Officer, in addition to retaining his role as <FONT STYLE="white-space:nowrap">Co-Head</FONT> of Life Science, and Adam Mabry,
previously Senior Vice President &#150; Investments, was promoted to Chief Investment Officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Healthpeak&#146;s financial and operational results
over the last several quarters underscore the momentum of the business, which positions it well to continue to succeed and deliver value,&#148; said Brian Cartwright, independent Chairman of the Board. &#147;On behalf of the Board, I want to thank
Tom for his many contributions over his <FONT STYLE="white-space:nowrap">six-year</FONT> plus tenure and setting a solid foundation for the business moving forward. Scott has played a critical role in Healthpeak&#146;s performance and we are pleased
that he will step into the CEO role and welcome him to the Board.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Brinker served as President and Chief Investment Officer of Healthpeak
since January 2020. He was previously Executive Vice President and Chief Investment Officer of the Company. Prior to joining Healthpeak in 2018, Mr.&nbsp;Brinker served in various investment and portfolio management-related roles at Welltower Inc.,
a healthcare REIT, between July 2001 and January 2017, most recently as its Executive Vice President and Chief Investment Officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the appointment of
Mr.&nbsp;Brinker, Mr.&nbsp;Cartwright continued, &#147;Since joining Healthpeak, Scott has consistently proven his operational expertise, strategic acumen and experience driving growth and profitability. He has been essential in both shaping and
executing our growth strategies while maintaining a disciplined approach to capital allocation. Scott is exceptionally qualified to serve as CEO and the Board is confident that he will continue to deliver long-term value for all our
stakeholders.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Brinker commented, &#147;I am honored&nbsp;to&nbsp;step into this role&nbsp;and&nbsp;excited about Healthpeak&#146;s future.
I&nbsp;look forward to working closely&nbsp;with&nbsp;our world-class&nbsp;team and Board&nbsp;to capitalize on our scale and expertise in life science, medical office, and CCRC real estate. We expect our high-quality portfolio and platform to
produce consistent internal growth through the inevitable market cycles. Our land bank and relationships should drive attractive opportunities for accretive external growth, while we remain disciplined&nbsp;about capital allocation.&nbsp;This is an
exciting time to take the helm,&nbsp;as our operating results and balance sheet are in good shape amidst a more chaotic economic environment.&nbsp;I am grateful to Tom for his substantial efforts and&nbsp;I look forward to&nbsp;building&nbsp;on the
successful foundation he built for Healthpeak.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;It has been a privilege to serve as CEO of Healthpeak and I am deeply proud of what we have been able
to achieve together for our investors and stakeholders over the last several years,&#148; said Mr.&nbsp;Herzog, outgoing CEO. &#147;I am confident that Scott is the right leader at the right time to drive Healthpeak forward, building on our strong
momentum and continuing to generate sustainable long-term value for our shareholders, employees and customers. I would like to thank the Board, Scott and the entire management team for their partnership and I look forward to watching
Healthpeak&#146;s continued success.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Bohn has served as Executive Vice President &#150; <FONT STYLE="white-space:nowrap">Co-Head</FONT> of
Life Science since February 2022, previously serving as Senior Vice President &#150; <FONT STYLE="white-space:nowrap">Co-Head</FONT> of Life Science. Prior to joining the Company in 2012, he held various development, acquisition and leasing
positions at Terreno Realty Corporation , AMB Property Corporation and RREEF/Deutsche Bank. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Mabry, a CFA charterholder, has served as Senior
Vice President &#150; Investments since September 2018, previously serving as Senior Vice President &#150; Corporate Transactions from February 2018 to September 2018, and Vice President &#150; Corporate Transactions from June 2017 to January 2018.
Prior to joining Healthpeak, he was a Vice President at The Wolff Company and a Vice President at Barclays in the real estate investment banking group. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About</B><B></B><B>&nbsp;Healthpeak Properties </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&amp;P 500 company. Healthpeak owns and develops high-quality real
estate in the three <FONT STYLE="white-space:nowrap">private-pay</FONT> healthcare asset classes of Life Science, Medical Office and CCRC. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for
long-term growth. For more information regarding Healthpeak, visit www.healthpeak.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Andrew Johns, CFA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Vice President &#150; Investor
Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">720-428-5400</FONT></FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Statements contained in this
release that are not historical facts are &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended.
Forward-looking statements include, among other things, statements regarding our and our officers&#146; intent, belief or expectation as identified by the use of words such as &#147;may,&#148; &#147;will,&#148; &#147;project,&#148;
&#147;expect,&#148; &#147;believe,&#148; &#147;intend,&#148; &#147;anticipate,&#148; &#147;seek,&#148; &#147;target,&#148; &#147;forecast,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;estimate,&#148; &#147;could,&#148; &#147;would,&#148;
&#147;should&#148; and other comparable and derivative terms or the negatives thereof. Forward-looking statements reflect our current expectations and views about </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
future events and are subject to risks and uncertainties that could significantly affect our future financial condition and results of operations. While forward-looking statements reflect our
good faith belief and assumptions we believe to be reasonable based upon current information, we can give no assurance that our expectations or forecasts will be attained. Further, we cannot guarantee the accuracy of any such forward-looking
statement contained in this release, and such forward-looking statements are subject to known and unknown risks and uncertainties that are difficult to predict. These risks and uncertainties include, but are not limited to: the Covid pandemic and
health and safety measures intended to reduce its spread, the availability, effectiveness and public usage and acceptance of vaccines, and how quickly and to what extent normal economic and operating conditions can resume within the markets in which
we operate; the ability of our existing and future tenants, operators and borrowers to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and manage their expenses in order to generate sufficient income
to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations; increased competition, operating costs and market changes affecting our tenants, operators and borrowers; the financial condition
of our tenants, operators and borrowers, including potential bankruptcies and downturns in their businesses, and their legal and regulatory proceedings; our concentration of real estate investments in the healthcare property sector, which makes us
more vulnerable to a downturn in a specific sector than if we invested in multiple industries and exposes us to the risks inherent in illiquid investments; our ability to identify and secure replacement tenants and operators and the potential
renovation costs and regulatory approvals associated therewith; our property development, redevelopment and tenant improvement activity risks, including project abandonments, project delays and lower profits than expected; changes within the life
science industry; high levels of regulation, funding requirements, expense and uncertainty faced by our life science tenants; the ability of the hospitals on whose campuses our MOBs are located and their affiliated healthcare systems to remain
competitive or financially viable; our ability to maintain or expand our hospital and health system client relationships; operational risks associated with third party management contracts, including the additional regulation and liabilities of our
RIDEA lease structures; economic and other conditions that negatively affect geographic areas from which we recognize a greater percentage of our revenue; uninsured or underinsured losses, which could result in significant losses and/or performance
declines by us or our tenants and operators; our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our partners&#146; financial condition and continued cooperation;
our use of fixed rent escalators, contingent rent provisions and/or rent escalators based on the Consumer Price Index; competition for suitable healthcare properties to grow our investment portfolio; our ability to foreclose on collateral securing
our real estate-related loans; our ability to make material acquisitions and successfully integrate them; the potential impact on us and our tenants, operators and borrowers from litigation matters, including rising liability and insurance costs; an
increase in our borrowing costs, including due to higher interest rates; the availability of external capital on acceptable terms or at all, including due to rising interest rates, changes in our credit ratings and the value of our common stock,
volatility or uncertainty in the capital markets, and other factors; cash available for distribution to stockholders and our ability to make dividend distributions at expected levels; our ability to manage our indebtedness level and covenants in and
changes to the terms of such indebtedness; changes in global, national and local economic and other conditions; laws or regulations prohibiting eviction of our tenants; the failure of our tenants, operators and borrowers to comply with federal,
state and local laws and regulations, including resident health and safety requirements, as well </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as licensure, certification and inspection requirements; required regulatory approvals to transfer our senior housing properties; compliance with the Americans with Disabilities Act and fire,
safety and other regulations; the requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid; legislation to address federal government operations and administration decisions affecting the Centers for Medicare
and Medicaid Services; our participation in the CARES Act Provider Relief Fund and other Covid-related stimulus and relief programs; provisions of Maryland law and our charter that could prevent a transaction that may otherwise be in the interest of
our stockholders; environmental compliance costs and liabilities associated with our real estate investments; our ability to maintain our qualification as a REIT; changes to U.S. federal income tax laws, and potential deferred and contingent tax
liabilities from corporate acquisitions; calculating <FONT STYLE="white-space:nowrap">non-REIT</FONT> tax earnings and profits distributions; ownership limits in our charter that restrict ownership in our stock; the loss or limited availability of
our key personnel; our reliance on information technology systems and the potential impact of system failures, disruptions or breaches; and other risks and uncertainties described from time to time in our Securities and Exchange Commission filings.
Except as required by law, we do not undertake, and hereby disclaim, any obligation to update any forward-looking statements, which speak only as of the date on which they are made. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>peak-20221006.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 10/7/2022 1:01:01 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:peak="http://www.healthpeak.com/20221006"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.healthpeak.com/20221006"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="peak-20221006_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="peak-20221006_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>peak-20221006_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 10/7/2022 1:01:01 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>peak-20221006_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 10/7/2022 1:01:01 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="peak-20221006.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140197119995200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000765880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  06,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Healthpeak Properties, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-08895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0091377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5050 South Syracuse Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(720)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">428-5050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, $1.00 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PEAK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d335330d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="peak-20221006.xsd" xlink:type="simple"/>
    <context id="duration_2022-10-06_to_2022-10-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2022-10-06</startDate>
            <endDate>2022-10-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2022-10-06_to_2022-10-06">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-10-06_to_2022-10-06"
      id="Hidden_dei_EntityCentralIndexKey">0000765880</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-10-06_to_2022-10-06">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-10-06_to_2022-10-06">2022-10-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2022-10-06_to_2022-10-06">Healthpeak Properties, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-10-06_to_2022-10-06">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-10-06_to_2022-10-06">001-08895</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-10-06_to_2022-10-06">33-0091377</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-10-06_to_2022-10-06">5050 South Syracuse Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2022-10-06_to_2022-10-06">Suite 800</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-10-06_to_2022-10-06">Denver</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-10-06_to_2022-10-06">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-10-06_to_2022-10-06">80237</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-10-06_to_2022-10-06">(720)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-10-06_to_2022-10-06">428-5050</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-10-06_to_2022-10-06">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-10-06_to_2022-10-06">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-10-06_to_2022-10-06">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-10-06_to_2022-10-06">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-10-06_to_2022-10-06">Common stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-10-06_to_2022-10-06">PEAK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-10-06_to_2022-10-06">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-10-06_to_2022-10-06">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    "  ABD95)!Z;HJT
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M2P$"% ,4    "  ABD95!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( "&*1E4=;>MC[@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M "&*1E697)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ (8I&5?7WYI-F!   ,!$  !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M "&*1E6?H!OPL0(  .(,   -              "  :D,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ (8I&59>*NQS     $P(   L              ( !
MA0\  %]R96QS+RYR96QS4$L! A0#%     @ (8I&51PX9>H_ 0  / (   \
M             ( !;A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( "&*
M1E4D'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( "&*1E5ED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d335330d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d335330d8k.htm">d335330d8k.htm</File>
    <File>d335330dex101.htm</File>
    <File>d335330dex991.htm</File>
    <File>peak-20221006.xsd</File>
    <File>peak-20221006_lab.xml</File>
    <File>peak-20221006_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d335330d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d335330d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "peak-20221006_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "peak-20221006_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "peak-20221006.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "peak",
   "nsuri": "http://www.healthpeak.com/20221006",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d335330d8k.htm",
      "contextRef": "duration_2022-10-06_to_2022-10-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d335330d8k.htm",
      "contextRef": "duration_2022-10-06_to_2022-10-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.healthpeak.com//20221006/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-22-258944-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-258944-xbrl.zip
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M )Q'X2N2Z\ MS_ /7Z FG$T08Z\UI* .D 8H=#*=.Z&*J)"YZ!5YA >$1XJ
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M<;FC35B"W%)K"GG,M<<4&CKRB+H%/.L>U%?D<YG\Q.1_Q2-@,Q:&J)*OQ"!
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M2Y-KN5O'35!57P;XN@MI$H+C&+5-"*[J")U7.L(;P3?@)/L7_P]02P,$%
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MCK!NFF($DH>^J<Q7!O@[1:F*7./7>.A5,X+7T[@$5K*+A[  CM:!'#OPX*^
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M\"S@0:U]IKOGG5XUB[,,%E=W+:C4OS6Z LIBE.6S3G0&+Y8&'<R,;3!M;Y7
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MBHH5_OLL@&<*5P G_P3W;%:'XRQ C1K'HXSD;FM51<D09[T*U,/*$DTQ'C=
M\( U3$ITWL4\!5Y3,!;@FUE165K []+\UZ9<6G3?=4C\*0@,;*/):CQ'QS&
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M- EO;O(,%0VQ,GCOQ>KS-(O;V\J(I_$(D/JH2(#*O:_?(YV>EZQ(>-^_PKE
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M'5LN+.DG5FX@@-%!DKG-K@'-]A8O^^C\U64/9IATS@#BBO >CL5ZS]?!6L
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M^C5>.NH1B9S:,G^G9X@1&)=<F5QS/HGS$=W"CNM,CT#;T65+%[U[=>Q=2JO
M!^[R7SM$.KP;EU8MD>P.@5+DK9L=4-C.-@Y3QAT@OMB[]"4!3.SP6>14<%JG
M)CEQ<_H+KEZ:=K70G/#5=D T1!LXNSU)GG(2^VK#@<HK;POB$G"TFO.1V9/L
M^NA&2@JL@3#J5/PRJ.T0(V7RL@M"N:7,EE<+SVD7?C!B_QFZ%H#J6D&<+^BJ
M@.T'3)V*(3HA+=H*_P+?DCL%LY;2<9/5$:F)?FZ8^%W00.&>4I5>?R1 ]0F0
MNAZ#6.=S62>[]]1PUE34:B*F^!![D/0-<$@D?Q_!-^# RH28O]X]H\2MJ)(
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MP]^[/P%13RY5Z"9'BG]BCB3^EOHV%2;,MX_:O=0M3*)6)JOD"(A;RNL3@QH
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M/56O^NK-^;O^Y5G_&*\XP(L/CL[/KH:7U_#%X$SUCH[.+X][9T=]OKW@^FR
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MF?RY7"2>%*OEC)LM@P=2;[X/-45"(KEQS #I/5D^]MZ9+,ZG#;48D*Y#Z)H
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M@"S_G"O[9O;\&<R>;Y8#*Q,KR_A$]0&DX/GQ+_#ER?#MZ>'_ 5!+ P04
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M"IY\>QZQ ]?;6FH&YU3RF*O'WWWY)1^)ZI*.-G()T+OO/Y[>\_[T?<8=$LE
M7Z4#(3"_>'#Q$$A6M#E594K"*3F9I)TL_"A]KD<C D4^0:+"@M1SO;!YCB1$
M"6>FH,(OG$E*.H',839R*2D)SK:\D18ZH*30U3G5"+(E/28B+_4V9G!R@4J"
MNU>05/X3XX>+PX%<E4EWG^0EK<WN15YOOGN-2A2976'CN]>],7>[5QH8J-F;
MANH!&1+1O646NMJ[XAHIV.Y>!L38\F#JC/*U/5$DE^*VI405'F,-L3(Y/M><
M.4I$Y@A*R0W%(*_"L5,%!=-5SG-KX^8<EAXRF]K,BUBK@R76A)2)KB7XKZW9
M^%"X_$_]Y7= V' @U5T%RZU"U8X@R;<S,GL^%+?^3F[0>7Y-,,>HP+C&AH-T
M8U'!YS(MYS;<(<&*"X/W!\/ R;Q/Y&*M$.[9'6+XL?J)BY@/XV%J&\,!UQ/G
MFLA00 7>A/=MN1)+V1@5G)/V,V,RY9V4.F9T1JG:%584K2RA2$S4L"VU(&M&
M<DG#UES3Y.W3'G>,TG%%B1W4RP'#C(NY'!M@[VU-MA^'I8BP0'X#N1FIK.H,
MJ]#9ED1":0KCU9XD^ Q"1'$8=U0(.P+N][V>"G)/U7<5]YRPJN7S!Y5/;^>6
M !I:Y.:3FNAO,Z9\RYL'7^XBPJSM(V-A2RN=#<]"B6!M<[@B @S5@OF420BI
M[$S/#7@^ B$4PF,V'(NDC8,K]G1XZ+$DG4L/D5YK6X3#K:2/AT_"N>S?S@K,
MU'JXO]A01F=-K&VH8XVO=&PNDEVZC?JEM=E=(;DD%:%()E21AUXJLJ"B+V4G
M#1%T4A*]P+-QD1N49B>^,\/G))0['8:#C0GOFXEL1O;!KL-&"&(13N.BUV$A
MFCM'Y,58VYRYNJ:S6A^:)2"K)A3:L)!5:&Z*/0(L6JK0PUJYJXG4;8WT-L3S
M/#)[*+4.?$>&@F3;4!N4TEZX0_Y2A7$1DTV]5X;L)L"(KI2R;4DG#W4\]"T<
MA(;T3&P8MUO?\84H%S:#C$NW-BF,E)KLSL[IP!'*)@@8A?S0U@D(3;K]Y!S>
M3&,%#U(E^B9N3PYZ0ANIX%\D,A_3@JCS'H0<#H)N/S;"*#@4S=A%?:Y0U.VJ
MR6Q0 O63P2XJW^^W5_(H5F-QM4"<+@(^+]J"9N3B.G72$&N;2$QV%9W3AS(:
MEGI_9M\54I)<=A4+<9[[ F,W#RG90Y=4K\93Z[8@FR"0IL)]MWZQ1S)4"CEA
M#*XQDUXW<7*!Q!+(9%?<N9*WR)2C,&"$SO-LL=5$P,I61$W8^!30V\+%\W0W
MDWTC"WQS&WIOLI9S=="Q+):R67D) $3]T:2=NBA=J-Q:A-E;5J( /B%?Z\)3
M#'*9Y6H*$RG"#5E7)]B=\BG@,.E]XZEY4<J6W$4@E\GMN7)"<M@Q*6' V#1>
ME=,X/^JNYH:K9>*6U $B/01>%"*QT>23SCD2D*,S7,2R4+ ."MI.N) #(\22
MO=@5RX"];]Y*?:0V4$QMPEH"HNQ%FBUE6)(&D&S2$^.HE0,H94-UG@]'/9VB
M;/"-0G6Y:KG>@X%>OWTN@9./3D-SF7@./!]#\<7$W/T6UEAZ@22"S.&@@Q0Z
MWZU[[T<P65LR^0,[2Z$6^XUP%Q<K,4G"H\RGLH)1=.>0>;+;E2?QN3>GT(EJ
MZYS/7+;IF0SWJU'*FMH&BR\T4'*;7U25&(25#5BIE#%;N[ZZG)XKR8RA;L0>
M"M^3O4@9THHN2C+=B/E#3S$7QBUJO5K2:P364D 6-.$S\,R!F/Z*-:H%[C=D
MGJ8FV*)P%. U1*H)3,=61"9RDC'7X^+WP@E&RLC">86[$DXD[#<\29MXY.JT
M,VXXR$U&Y_">#+)EIIB ^RX^3)(CR0Y$J>3=**+I3'B"L4,ZU.;'ZB,HD0)L
MKR$V?9W=T6X]==IA&5(I!-PR86B;I:O)RJ)-P6*LD!XY18S';R$%?XC,]^=L
MF>NL#*DC#1%R\+E]SR5@2N6HL8,W.PIO+L1:\3]")5YC)\B]5P)KE^-Z,,6*
M^%--1TU8]14T]WZ21FT^2O1M:,LX#$16?OM!M=(]P?>-(0<.R32?.EX4(W9!
M+7%T+LPQ@%FZR+(+BEW;'-&7PT#"%(<R\YH;:/LC+Q^9?&A)2.OIM/]RLAM*
M"-8U)4=5RHL^2@;9=<A9%^+ 6$JS1RZ %_0GNK58#/L(FPN'K0FWCG1DT(H)
MR30=:TH'S:7WBD"?N1HF-=0%B-U%?$YX.UE1U_02NUC( (6J,UF(-0?*4(KB
MGKG"/G;G&G4A*JPYHV2&;Q+IZ4*VG(@'[* ^+,SN&Y?=C8:#M2/TDW76.Z$H
MA+RXXL#O1PG:43F071^YXS+N6=)@ZN+I>H7E]P&8+[8GW,-\V99RQ'.0DWSG
M;3XIC5$Y!-E[3)'INKA";F9XE),D?CSX^CK@EJTD-<OZWU#Q68LH82X9:#K*
M))7SHG S#155,20)C\@.4J>]@# !IFU8R7W(X>YX_K$9*=>L;1:9:6+_@6U#
MN$34?B/!ED2II!X3CI!S$"JX^B@DXLFB>54)<:-E[7A0K/D?9K*[E$9[Z6?_
M3U'K=Q6U(#YD=X;#-QR;,)X"=!>K %HKJ7OOR'T2OSW O,FXZ;QZ;D(_C)SG
M+%WK U,.X43"3PBCW>][SA&DB"8("U:7UO?\B$KKG+MC=C(L,8K>]A.#FH2#
MZ7[=,.01.4/OA".UH-R7V3H3,UO.VMH+E<,Z$3W*OAHNIY8U<U'Y;$'9D0=:
M'^@<96!Y7A,*!.M/)DCR9JF;Y*6MK(^Y860<:6;,<9L-1EH:XPJ@.@P0UZ!N
MJ$TA,P&BB(A(Y9R&#9!Z<7X]O6'QO2/:0/6$:RD#OFBK/)$@%Y2Z($QE\+9H
MH[?R"U$NDY2! "->ZWK+G9MP[PYN0Z=&6@9=,96D?L:F[VJ0!TJ]E65LJ(%U
MUIU)=S&(&GBD9:N']DG: <E\J[.I/D5,2?8^E=]C(!],9/L$ ]=#7W76':MH
M[N*?)!:F_C&^&7?&(+4:U>CWC(&C\..!2$ER,Z?NG#PABDSW\/QPD.Z 64C6
M=8>D-(@B8Y&Q$\" /GHR6;GJF-8<CR-I:4;751?,8Z*Z$QXGU%@06LVX(MG3
M@53?I#*X<I,\;6/+'?0G'DJY 'E4K&SN\1C1]YW94IK@75698G+ O]/C^L9D
MR\H5;K'M4LJ#.D)'_N8Q#0RQ#BK!1JD@%.O4% NRI?'I2<Y#%=L<W!LR,O$7
MA[$AF/Z&C2?GA?1^=V9X 8IDO?0F8.N0_G@XF'(7/QE6![C(BF Y7!G/'5>$
M.06C1LQ0<86CX"'J:"ZT+4=<'W>S(A)6J@.N<HG'VP\4O6,:YZ6/I))?FH3D
MG]]WH>I*5[:<ZE/9</R!8'SZB'Z=CXO\H_[_ U!+ P04    "  ABD95)!NC
M"D,#  !9"P  $0   '!E86LM,C R,C$P,#8N>'-DO59M3]M($/Y>J?]AZD\]
MZ>RU@VB%1:BX4B0D2D\IK>Y;M;$GR:KK7=_N&LB_[^S:#DX@:8#3H4AL=N:9
M>>9U<_SAKI)P@\8*K<91EJ01H"IT*=1\'#4VYK80(OIP\OK5\9LXAK/SBRN(
M8>%<;7/&;F]ODW(FE-6R<63!)H6N&,1QK__Q^AM\;ZWG,$&)W")4W#HT\%<C
M9)F/TM$HS;+#)!L-<0:Y-P@E=YA#EK+WS&M"EJ?^ Z>?X5,PH^!:5#B$ZGII
MQ'SAX&WQ!P30F58*I<0EG O%52&XA*\]Y3_A0A4)G$H)$P^SQ-.BN<$RZ:S>
MV3*WQ0(K_OH5 "5,V5R1R:8:1SX372+NID8FVLQ9Z0QSRQH9*<6DA484T0#Z
M>]P##%7"2^P*..-V&D"]Q*<GB],L/L@&N!KYSS5G"^32+?QU*)5/3Y:F[P:0
M$L4*$:A9+)*YOF$D"$X&NEXN'@]FE*8'C#K#4;YQ )%"_=R!\.(I-<G0R0/(
M[4$ 9$='1RQ(-RB5;CV"SOHA:X5!FSMGQ+1Q>*Y-=88SWDA"->K?ADLQ$U@&
M+>K8"I5;TUG7<-S,T5WQ"FW-"WQBLJFU'HN,R&;LG\^77T/712<> ! :452U
M-@[:?KS411B3'0GUW^*^#K&_BK,1-4E"QB)0C_+>4D1@+R;2E_=91%:]L3<1
MNZV'_2'VAVW>'^_\9V=@<[1]_$<^_NS=7O$_6 W_ 1.MKEY*9K#?GE\3Q471
MKJ_VN']=[I$OZLU^+_@\'.YTO+E(.J_!)U=*N^!HR(37M5 SW5W1I6_BO._D
M"<X@++"<F\)HB;O7'*N-KM$X0>O^?AA: PN#LW'D=TW<[YD?DD\3VC.]R@,'
MZ^/EQ8P@*"_OZ?58)YP'7WHQ>#F]FURN3/MV&$>6\BX'X_D_AUL;?&JX!+&T
MWT/9MD?]]T#KR<%[/]>D ?[P;7*QZX58/1',\3NM=+5L:9[IHO'O4/__5)6?
M%)%;7E!OF2H0BT#06S(A]1][J:]H]D1+I%]R(C0P4: _^J'76Q@>N2JA-0<#
M>\=LT\BF_<9B^46=A'/!9='(5=H[<*>Q"[A9L/V1]\RVX[K;OF3](+/-2>YN
MAA/?7K4;A[[^ E!+ P04    "  ABD95)#>F*7@&  "Z1@  %0   '!E86LM
M,C R,C$P,#9?;&%B+GAM;,V<;V_;-A#&WQ?H=[AY;S:@LB,7PQ C:9$YR1 T
M;8+&W88-0R%+C$U,)@U2CNUO/U)_&CFF9"H\50':1I'NGKM'_IW*2'9.WF\6
M,3P0(2EGISV_?]0#PD(>438[[:VD%\B0TA[()&!1$'-&3GM;(GOOW[U^=?*#
MY\'YY=4G\&">)$LY&@S6ZW4_NJ=,\GB5*$G9#_EB )Y7Q(\G7^"/K-P(/I.8
M!)+ (I )$?#;BL;1:'@T'![Y_B]]?UC.$R30@A %"1F!?S3X=: CP1\=Z3]P
M]A$N4AD&$[H@Y52^W HZFR?P4_@SI$GGG#$2QV0+EY0%+*1!#'=%RV_@BH5]
M.(MC^*S3I.I3$O% HGZN&E/VWTC_,]7=P^M7 .HT,IGN.^WIDY&?B\U4Q'TN
M9JK7H[>#(J7WF+'92UF_31/\X^/C07JT'"VI*5:)^X._/E[?A7.R"#QU^M7+
M%>9E)!W)=/\U#]-3:-$@5$;H[[PBS-.[/'_HO?7[&QGUWNF"^=D)IB2^5EN0
M>A@)'I.:POIP6KV7QR?;I8HGFX2PB.3*W[1YF$?-!;G/5#5\J:0D87_&'P81
MH1H07V]X>D-W^*/ZYNN8*][/IC(109CLUHOU*>*BV)F:..T9D@:[#>FX,Q'N
M: 4B+'34Y@'_><0@Y.IU6R9>JEBDWPN^,':1E^.&@U_C:6QL4Y.DMO1X$^9]
MN3OD-1,J&Q-$\I50>#5Y:5,_[U)E^*?0_O=D\%C[I;2J+B&27#?MUPW)LX7"
M7/U-+N-@9HODDZ2.D#2WS@T'79 T""$A^4T9M+0SD"TT6@;2MELW'"]80I/M
M6)4107RE+L";#V1KBV5%<D=XUEOA-4$NN-8((F&;58"\!*0U0!5Q!KC%ULL@
M-^_?#>ES'J[TW$Q4][8D[^9T!+"Q<;Y_S 77?1TD2@MAT,K.:.*W62;2LE<<
M#&^)H#RZ8-&Y^G&F*8]/DCL&TVR%UP1AH&H0Q&8V*P&J!N@B:/BVT+J18^O^
M,18+G\F,ZD4R2SX%"VNBS;F=+A4JC/#J&/>%@DD/=YWP6 %T":150AM]&Q8)
MULUC@'S%0BZ67*2W2NX2-3ACOE*+E.V81PVY/B#5*>9V-KEUBOL06,CCSL1.
M04@K0EX2=$VD(?D.O@PS\WQS&$-T26/R:;68$M%L8LIYG8Z'P0 W'W<'_ZD6
M+N5:'3)Y)*"Q^S70:]4T!JB38',5J<42O:?9S?'G4%LITBG"AZQQBV!WN&N%
M<4E7I6"W%B[WK5HQ#,$S_&",Q%D4*0,R_W)-&?&;C8-1H--1J+/$#P2ZCT"E
M*"[^N?Z;8@-T);AA6.N8UFP8T'^&EW;0'[JB/WQQZ ]MT1^V@?[P^Z$_6?/6
MT$>R88U^K1=$],=J\T9,^)H]"_QR^DO WF#'!/UC&!KR3R5; EZ7 2Y %\*%
M'=M '>IV+A Q3W\>OA&W@C]0%C:\K5.E\1* KS)FHOY)+!KZ1MV6^,]N;"AT
MBFJX0]"*E;I):. '<1QNN4R"^&^Z;'Z/TZSP$D;!;,HT"#N1:&-@4&UI"+)*
MH$IAWK=LST;= %A[<7P/H#8H2- $^-V<KMX!:&J<[Q]S>O_?G@X2N.G_\UH9
MAU/\/G?>^V?9K!N(^DVY\>V<LX;WR_?S.@*RT@ W'W<!TZR%!&<J#JDZUGW#
M=OHM0]JD:3=0_Q0T20@;\\5BQ?+[D=*6UHKDCI"MM\)K@ES@K1%$(CBO +LE
MG"ENL?$RRDV[=\/YCL<TI EELX]JQ2UH$-NR;,KL".0:$[PJP@7A*C4D?A_E
MH=!WAK>MELOD-NK;#=M;0?1\$(5%^DY(_>D8<7-_;[]PJ%/H"&,+4_Q0I O6
MAU21\%9EH%P'LD*05G(&O6T39>"?Z005_2LI5T2X#X!!YV6,0;5!\S#LQ2..
M1(5V6X.1E6MU/EIR5#LEC6PY+F](N%+KJ:T_G$YH$EO?X]C/ZVII4V6 FX\[
M+6N,6EB+FEP<E#JD\NYKFE;ZW5G1-&C:#=2)"/1GS>^VBRFW7H(_2>H(47/K
MW'#0!4Z#$!*9N3)DTLY4MM!H&4G;;G&NFQ>;<*[<DB8?9C#G=GS]-!KAU3$8
MU]%]/>QK:5$!Y\,,[?5MO*9:-H_Q?.]B0<1,3<WO@J^3N5J,+ /6\(.\%1*=
M/N&KM\4/AKH_XZN116(]?S!6%(*L$N2ED)[QM6C#\)#/UDMYQ[7:TK]R)=]%
MLU\\HO;\#U!+ P04    "  ABD95$:*2[,$$  !$+   %0   '!E86LM,C R
M,C$P,#9?<')E+GAM;-6:76_;-A2&[POT/W#JS09,EN4T[6+$*3PG*8SE"XZ[
M#;LI:.G8)DJ1 DG']K_?H6QNEBVG=MH-8A#X@^)[^/(\%"U2.O^PR#AY J69
M%)T@;C0# B*1*1.33C#3(=4)8P'1AHJ4<BF@$RQ!!Q\N7K\Z_R$,R>5U_XZ$
M9&I,KMM1-)_/&^F8"2WYS&!(W4AD%I$P=/5[PT_D]U5S;3( #E0#R:@VH,BO
M,\;3=JO9:C7C^+01MS9U"J@-2%)JH$WB9O0^LC5)W&[:?]*])5=%&$&&+(--
MJ<R7BDVFAOR8_$0*T:44 CB');EF@HJ$44X>G>6?25\D#=+EG RL3*-/#>H)
MTL8Z*F?B2]N^C*Q[\OH5P3],I-!%:2>PZ5AG8S%2O"'5!-TV3R(G"C8UBQW1
M_*20Q&=G9U%QM%Q?LZK:V$ <_7E[\YA,(:,A0D!HR593Z"8U_Z@WS9U&JX.N
MOF9M742ZD4F1^@.Z1?;6L-]"5RVT16'<"D_BQD*GP85M<I55)3D,8$SL^Z=!
MO]3F%"@WTQSHEV)4%?SC9O-=9.A""IDM(ZN*+F4RRT 8]]X5Z94PS"S[8BQ5
M5O0E($5:VU,%XTY@0X8NFG7T9H"!/A\3R"QS/#4TRW(. 8DV>I0K'#W"%+5O
ML* D@(4!D4+JPM@._&=]OEB170]?F91RX,[@ IN&I#&13U$*S+88VP\V006N
M-_CE<T_BI-$=::-H8LI)X':\2.4*.1T![P05HNA[&NIBMU/;]6M.)X<:VA*5
M#6V"ZZJD%)*JQ(7#CSO4RF-_72/*J<)X83+%:<ZIQTIFE<E9MR8KC4J5@NH$
MK58#S_F Y(I)A;"Q)" SC5YD;EU3;H_!&)2"]&;5[;TN"XLX?VHH:GYG/*O1
MV,,>*,K[..07O\'R4$Q[Q/7%M<>PPW;B#38WGPPQC8?2*FOJ"ZGLT[$Y]8[-
M Z!7G.[32[PT.A;2EKC^M+8,.VSOO,&VFAL&,&&VH\+<T>Q@:M7:^D*K]NN8
MO?>,&2X+I,JE*E+[B!F&GISA%+_LR?1(A%\)57>B7['O /_B&>!KQN%NEHU
M'4=S4U=W=)M>':<SSS@-Z:*?8AK8F*V6IB^!MC=(W0GN-;[&>=+T#&<W33')
M>OV&:V2(CT-9&:#N&"M-.X2Q]PA;WXJPY2/"UK\(?5N;KWO1PX_W:BCGXD4
M-^6>X-NT[.#YLT(O=:6X%+M7#TH^,;OU^Q*".S$\P;CCV[%\ZR?+!ZD-Y7^Q
M_/C5174$3SANN784_=F7L?-)5P$]AEM94U]299^.C3^;+_9>%G^82G'D.F]7
M5U]&NUX=)W\V7/Y ?P9$3V;93*R7.?I06'O$]26VQ[##YL\VRJ/D+&&&B<DM
M_A@K9JT=QJQ*65]@56X=+7\V4QX4V"$'>+54W >Q=Z+5_7A\^+3X7(3ZTGO.
M]9KB6W_V4+9ZT]=Z!NK;65;$\89HA7?'U9^-E4=(9M9BW!H-F>$'7TKNZNK+
M;=>KX^3/[LE04?NTW.,R&\F#?^ZV1/4EM&74X?%G?\0-L:M%,J5B L?<;JW6
MUA=6M5_'S+=]D*L,U 3'WD<EYV:*\WM.Q9&/#.T)45^"S]IV(/^'K9#S:"<U
M-UA@'WY=';$O]E%.+/D;4$L! A0#%     @ (8I&506 0H4@%@  <9$   X
M             ( !     &0S,S4S,S!D.&LN:'1M4$L! A0#%     @ (8I&
M5?(,*+MS+P  *[D  !$              ( !3!8  &0S,S4S,S!D97@Q,#$N
M:'1M4$L! A0#%     @ (8I&58A_I8<Z%0  VS\  !$              ( !
M[D4  &0S,S4S,S!D97@Y.3$N:'1M4$L! A0#%     @ (8I&520;HPI# P
M60L  !$              ( !5UL  '!E86LM,C R,C$P,#8N>'-D4$L! A0#
M%     @ (8I&520WIBEX!@  ND8  !4              ( !R5X  '!E86LM
M,C R,C$P,#9?;&%B+GAM;%!+ 0(4 Q0    ( "&*1E41HI+LP00  $0L   5
M              "  71E  !P96%K+3(P,C(Q,# V7W!R92YX;6Q02P4&
/  8 !@!_ 0  :&H

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
